Stephen Allan Smith

Title: The Innovations of Stephen Allan Smith

Introduction

Stephen Allan Smith is a notable inventor based in London, GB. He has made significant contributions to the field of neuropharmacology, particularly through his innovative work on AMPA receptor signaling. His research has implications for treating neurodegenerative diseases, showcasing the potential of his inventions in medical science.

Latest Patents

Stephen Allan Smith holds a patent for "Modulators of AMPA receptor signaling." This patent includes compounds of Formula (I) that have demonstrated utility in modulating AMPA receptor signaling. The invention aims to prevent AMPA receptor-mediated toxicity, which may be beneficial in treating diseases where AMPA receptor activation contributes to neurodegeneration, such as multiple sclerosis and other related conditions. He has 1 patent to his name.

Career Highlights

Throughout his career, Stephen has worked with esteemed organizations, including the Centre for Addiction and Mental Health and the University Court of the University of Aberdeen. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Stephen has collaborated with notable colleagues, including Fang Liu and Iain Robert Greig. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Stephen Allan Smith's innovative contributions to the field of neuropharmacology highlight the importance of his research in addressing neurodegenerative diseases. His patent on AMPA receptor signaling modulation represents a significant advancement in medical science.